Biotron Limited
BITRF
$0.01
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 591.20K | 607.90K | 0.00 | 0.00 | 536.10K |
| Total Revenue | 591.20K | 607.90K | 0.00 | 0.00 | 536.10K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 591.20K | 607.90K | 0.00 | 0.00 | 536.10K |
| SG&A Expenses | 248.60K | 255.60K | 213.70K | 213.30K | 243.50K |
| Depreciation & Amortization | 2.40K | 2.50K | 6.20K | 6.20K | 7.10K |
| Other Operating Expenses | 10.40K | 10.70K | 13.30K | 13.20K | 16.20K |
| Total Operating Expenses | 364.10K | 374.40K | 703.20K | 701.70K | 983.10K |
| Operating Income | 227.10K | 233.50K | -703.20K | -701.70K | -447.10K |
| Income Before Tax | 227.00K | 233.40K | -696.10K | -694.70K | -431.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 227.00K | 233.40K | -696.10K | -694.70K | -431.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 227.00K | 233.40K | -696.10K | -694.70K | -431.40K |
| EBIT | 227.10K | 233.50K | -703.20K | -701.70K | -447.10K |
| EBITDA | 229.50K | 236.00K | -702.90K | -699.20K | -440.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 902.32M | 902.32M | 902.27M | 902.27M | 902.07M |
| Average Diluted Shares Outstanding | 991.92M | 991.92M | 902.27M | 902.27M | 902.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |